Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 21411639)

1.

Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells.

Dhingra A, Fina ME, Neinstein A, Ramsey DJ, Xu Y, Fishman GA, Alexander KR, Qian H, Peachey NS, Gregg RG, Vardi N.

J Neurosci. 2011 Mar 16;31(11):3962-7. doi: 10.1523/JNEUROSCI.6007-10.2011.

2.

Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice.

Xiong WH, Duvoisin RM, Adamus G, Jeffrey BG, Gellman C, Morgans CW.

PLoS One. 2013 Aug 1;8(8):e69506. doi: 10.1371/journal.pone.0069506. Print 2013.

3.

Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction.

Kondo M, Sanuki R, Ueno S, Nishizawa Y, Hashimoto N, Ohguro H, Yamamoto S, Machida S, Terasaki H, Adamus G, Furukawa T.

PLoS One. 2011;6(5):e19911. doi: 10.1371/journal.pone.0019911. Epub 2011 May 17.

4.

Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach.

Dalal MD, Morgans CW, Duvoisin RM, Gamboa EA, Jeffrey BG, Garg SJ, Chan CC, Sen HN.

Ophthalmology. 2013 Dec;120(12):2560-4. doi: 10.1016/j.ophtha.2013.07.037. Epub 2013 Sep 17.

PMID:
24053997
5.

Degeneration of retinal on bipolar cells induced by serum including autoantibody against TRPM1 in mouse model of paraneoplastic retinopathy.

Ueno S, Nishiguchi KM, Tanioka H, Enomoto A, Yamanouchi T, Kondo M, Yasuma TR, Yasuda S, Kuno N, Takahashi M, Terasaki H.

PLoS One. 2013 Nov 25;8(11):e81507. doi: 10.1371/journal.pone.0081507. eCollection 2013.

6.

TRPM1: the endpoint of the mGluR6 signal transduction cascade in retinal ON-bipolar cells.

Morgans CW, Brown RL, Duvoisin RM.

Bioessays. 2010 Jul;32(7):609-14. doi: 10.1002/bies.200900198.

7.

TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells.

Morgans CW, Zhang J, Jeffrey BG, Nelson SM, Burke NS, Duvoisin RM, Brown RL.

Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19174-8. doi: 10.1073/pnas.0908711106. Epub 2009 Oct 27.

8.

GPR179 is required for high sensitivity of the mGluR6 signaling cascade in depolarizing bipolar cells.

Ray TA, Heath KM, Hasan N, Noel JM, Samuels IS, Martemyanov KA, Peachey NS, McCall MA, Gregg RG.

J Neurosci. 2014 Apr 30;34(18):6334-43. doi: 10.1523/JNEUROSCI.4044-13.2014.

9.

Depolarizing bipolar cell dysfunction due to a Trpm1 point mutation.

Peachey NS, Pearring JN, Bojang P Jr, Hirschtritt ME, Sturgill-Short G, Ray TA, Furukawa T, Koike C, Goldberg AF, Shen Y, McCall MA, Nawy S, Nishina PM, Gregg RG.

J Neurophysiol. 2012 Nov;108(9):2442-51. doi: 10.1152/jn.00137.2012. Epub 2012 Aug 15.

10.

Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy.

Wang Y, Abu-Asab MS, Li W, Aronow ME, Singh AD, Chan CC.

BMC Ophthalmol. 2012 Nov 13;12:56. doi: 10.1186/1471-2415-12-56.

11.

G-protein-mediated inhibition of the Trp channel TRPM1 requires the Gβγ dimer.

Shen Y, Rampino MA, Carroll RC, Nawy S.

Proc Natl Acad Sci U S A. 2012 May 29;109(22):8752-7. doi: 10.1073/pnas.1117433109. Epub 2012 May 14.

12.

[Paraneoplastic retinopathy].

Liu Y, Lei B.

Zhonghua Yan Ke Za Zhi. 2012 Jul;48(7):653-6. Review. Chinese.

PMID:
22943872
13.

TRPM1.

Irie S, Furukawa T.

Handb Exp Pharmacol. 2014;222:387-402. doi: 10.1007/978-3-642-54215-2_15. Review.

PMID:
24756714
14.

Ultrastructural localization and expression of TRPM1 in the human retina.

Klooster J, Blokker J, Ten Brink JB, Unmehopa U, Fluiter K, Bergen AA, Kamermans M.

Invest Ophthalmol Vis Sci. 2011 Oct 21;52(11):8356-62. doi: 10.1167/iovs.11-7575.

PMID:
21896854
15.

Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.

Milam AH, Saari JC, Jacobson SG, Lubinski WP, Feun LG, Alexander KR.

Invest Ophthalmol Vis Sci. 1993 Jan;34(1):91-100.

PMID:
8425845
16.

Voriconazole, an antifungal triazol that causes visual side effects, is an inhibitor of TRPM1 and TRPM3 channels.

Xiong WH, Brown RL, Reed B, Burke NS, Duvoisin RM, Morgans CW.

Invest Ophthalmol Vis Sci. 2015 Feb 3;56(2):1367-73. doi: 10.1167/iovs.14-15270.

PMID:
25650413
17.

TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade.

Koike C, Obara T, Uriu Y, Numata T, Sanuki R, Miyata K, Koyasu T, Ueno S, Funabiki K, Tani A, Ueda H, Kondo M, Mori Y, Tachibana M, Furukawa T.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):332-7. doi: 10.1073/pnas.0912730107. Epub 2009 Dec 4.

18.

[Case report of melanoma-associated retinopathy associated with positive auto-antibodies against retinal bipolar cells].

Hanaya J, Nakamura Y, Nejima R, Miyata K, Mera K, Ohguro H, Yamamoto S.

Nihon Ganka Gakkai Zasshi. 2011 Jun;115(6):541-6. Japanese.

PMID:
21735759
19.

TRPM1 forms ion channels associated with melanin content in melanocytes.

Oancea E, Vriens J, Brauchi S, Jun J, Splawski I, Clapham DE.

Sci Signal. 2009 May 12;2(70):ra21. doi: 10.1126/scisignal.2000146.

20.

mGluR6 deletion renders the TRPM1 channel in retina inactive.

Xu Y, Dhingra A, Fina ME, Koike C, Furukawa T, Vardi N.

J Neurophysiol. 2012 Feb;107(3):948-57. doi: 10.1152/jn.00933.2011. Epub 2011 Nov 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk